Matches in Wikidata for { <http://www.wikidata.org/entity/Q95315791> ?p ?o ?g. }
Showing items 1 to 32 of
32
with 100 items per page.
- Q95315791 description "article scientifique publié en 2020" @default.
- Q95315791 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95315791 description "scientific article published on 19 May 2020" @default.
- Q95315791 description "wetenschappelijk artikel" @default.
- Q95315791 description "наукова стаття, опублікована 19 травня 2020" @default.
- Q95315791 name "Adjunct Aripiprazole for Obsessive-Compulsive Symptoms Associated With Second-Generation Antipsychotics in 2 Patients With Schizophrenia: Anti-obsessional Efficacy of Partial Agonism" @default.
- Q95315791 name "Adjunct Aripiprazole for Obsessive-Compulsive Symptoms Associated With Second-Generation Antipsychotics in 2 Patients With Schizophrenia: Anti-obsessional Efficacy of Partial Agonism" @default.
- Q95315791 type Item @default.
- Q95315791 label "Adjunct Aripiprazole for Obsessive-Compulsive Symptoms Associated With Second-Generation Antipsychotics in 2 Patients With Schizophrenia: Anti-obsessional Efficacy of Partial Agonism" @default.
- Q95315791 label "Adjunct Aripiprazole for Obsessive-Compulsive Symptoms Associated With Second-Generation Antipsychotics in 2 Patients With Schizophrenia: Anti-obsessional Efficacy of Partial Agonism" @default.
- Q95315791 prefLabel "Adjunct Aripiprazole for Obsessive-Compulsive Symptoms Associated With Second-Generation Antipsychotics in 2 Patients With Schizophrenia: Anti-obsessional Efficacy of Partial Agonism" @default.
- Q95315791 prefLabel "Adjunct Aripiprazole for Obsessive-Compulsive Symptoms Associated With Second-Generation Antipsychotics in 2 Patients With Schizophrenia: Anti-obsessional Efficacy of Partial Agonism" @default.
- Q95315791 P1433 Q95315791-A73C8026-AC79-46CE-99D2-7967149744D6 @default.
- Q95315791 P1476 Q95315791-B45815C9-B737-4C2E-9FC3-BA44CB6C19A4 @default.
- Q95315791 P2093 Q95315791-1E37AF33-9E63-41ED-B6D2-DED97C13982E @default.
- Q95315791 P2093 Q95315791-5AD4AE4B-C3CE-421A-842E-F6032324F619 @default.
- Q95315791 P31 Q95315791-A7A091B7-6F2D-409C-9761-64F1040C6613 @default.
- Q95315791 P356 Q95315791-51CAC834-1576-485F-BF52-9A61313193FC @default.
- Q95315791 P577 Q95315791-83F0F188-460F-4F9B-BA44-0FD71C207CFA @default.
- Q95315791 P698 Q95315791-B5D3442A-BBE7-492F-8C54-06D6EFEC51E7 @default.
- Q95315791 P921 Q95315791-FE9FAB14-46F3-4FC4-96B9-0BCF27DDB8D1 @default.
- Q95315791 P356 JCP.0000000000001214 @default.
- Q95315791 P698 32433255 @default.
- Q95315791 P1433 Q6294969 @default.
- Q95315791 P1476 "Adjunct Aripiprazole for Obsessive-Compulsive Symptoms Associated With Second-Generation Antipsychotics in 2 Patients With Schizophrenia: Anti-obsessional Efficacy of Partial Agonism" @default.
- Q95315791 P2093 "Umit Haluk Yesilkaya" @default.
- Q95315791 P2093 "Yasin Hasan Balcioglu" @default.
- Q95315791 P31 Q13442814 @default.
- Q95315791 P356 "10.1097/JCP.0000000000001214" @default.
- Q95315791 P577 "2020-05-19T00:00:00Z" @default.
- Q95315791 P698 "32433255" @default.
- Q95315791 P921 Q41112 @default.